These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2860228)

  • 1. Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.
    Fuller RW; Hemrick-Luecke SK; Perry KW; Toomey RE
    J Pharm Pharmacol; 1985 Apr; 37(4):268-70. PubMed ID: 2860228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide.
    Fuller RW; Perry KW; Hemrick-Luecke SK
    Neurochem Res; 1982 Apr; 7(4):399-405. PubMed ID: 6125905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide.
    Fuller RW; Snoddy HD; Mason NR; Clemens JA; Bemis KG
    Neuroendocrinology; 1983; 36(4):285-90. PubMed ID: 6866215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats.
    Fuller RW; Hemrick-Luecke SK
    J Neural Transm; 1985; 61(3-4):161-73. PubMed ID: 3157777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats. Characterization by the use of antagonists.
    Fuller RW; Snoddy HD
    Neuropharmacology; 1984 Dec; 23(12A):1389-94. PubMed ID: 6527743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pergolide on MOPEG sulphate levels in rat brain regions.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1983 Jan; 35(1):57-8. PubMed ID: 6131970
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeated administration of pergolide to rats attenuates the acute elevation of serum corticosterone by pergolide.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1981 Dec; 15(6):933-6. PubMed ID: 7323119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
    Jiang DH; Reches A; Wagner HR; Fahn S
    Neuropharmacology; 1984 Mar; 23(3):295-301. PubMed ID: 6539428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists.
    Fuller RW; Snoddy HD
    Endocrinology; 1981 Oct; 109(4):1026-32. PubMed ID: 6116593
    [No Abstract]   [Full Text] [Related]  

  • 10. Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain.
    Fuller RW; Snoddy HD
    Life Sci; 1983 Dec; 33(23):2357-61. PubMed ID: 6645804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Sep; 34(9):607-8. PubMed ID: 6127394
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain.
    Wong DT; Bymaster FP; Reid LR; Fuller RW; Perry KW; Kornfeld EC
    J Neural Transm; 1983; 58(1-2):55-67. PubMed ID: 6655467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by partial ergoline.
    Rabey JM; Passeltiner P; Markey K; Asano T; Goldstein M
    Brain Res; 1981 Nov; 225(2):347-56. PubMed ID: 6118195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide.
    Wong DT; Reid LR
    Commun Psychopharmacol; 1980; 4(4):269-75. PubMed ID: 7273702
    [No Abstract]   [Full Text] [Related]  

  • 19. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
    Fuller RW; Clemens JA; Hynes MD
    J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
    Jiang DH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):209-13. PubMed ID: 4075909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.